tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shandong Xinhua Pharmaceutical Schedules Board Meeting to Review Interim Results
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Schedules Board Meeting to Review Interim Results
25d ago
Shandong Xinhua’s Subsidiary Secures Drug Registration for Finasteride Tablets
Premium
Company Announcements
Shandong Xinhua’s Subsidiary Secures Drug Registration for Finasteride Tablets
1M ago
Xinhua Pharmaceutical Gains Approval for Marketing License Transfer
Premium
Company Announcements
Xinhua Pharmaceutical Gains Approval for Marketing License Transfer
2M ago
Shandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Approves Key Resolutions at AGM
3M ago
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Announces Final Dividend for 2024
3M ago
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Heart Failure Drug
3M ago
Shandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Announces 2025 AGM with Key Resolutions
4M ago
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Epalrestat Tablets License Transfer
4M ago
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Reports Q1 2025 Financial Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100